All these data suggest that AH might constitute a risk factor for corneal diseases by activating/upregulating NADPH oxidase locally in the corneal layers, which eventually results in an oxidative imbalance, inflammatory, and fibrotic processes in this ocular tissue. The gene discussed is FMO5; the disease is corneal disorder.